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We conducted a group consensus review of thyroid aspirates that
were previously interpreted as ‘‘atypia of undetermined signifi-
cance/follicular lesion of undetermined significance’’ (AUS/
FLUS) and followed by surgical interventions. The study aimed
to investigate if consensus review would minimize the diagnosis
of AUS/FLUS with an optimal interobserver agreement and also
promote a better cytohistologic concordance. A group of
reviewers who were blinded to the corresponding histologic find-
ings simultaneously evaluated a total of 50 aspirates at a multi-
headed light microscope. Using the Bethesda System for Report-
ing Thyroid Cytopathology as a guideline, a consensus interpre-
tation was reached upon review of each aspirate. Interobserver
agreement was calculated and recorded. The cytohistologic cor-
relation was then performed between the consensus interpretation
and the corresponding histologic diagnosis. The consensus
review reclassified 26 (52%) aspirates as non-neoplasia/benign,
10 (20%) as follicular neoplasm/suspicious for a follicular neo-
plasm, 1 (2%) as papillary thyroid carcinoma, and 2 (4%) as
nondiagnostic. Eleven (22%) aspirates remained AUS/FLUS. The
interobserver agreement across the five diagnostic categories
ranged from 71.6% to 100% with an average level of 88.8%.
Cytohistologic concordance was achieved in 24 of 26 (92.3%)
and 9 of 11 (81.8%) aspirates that were reclassified as non-
neoplasia/benign and neoplasia/malignancy, respectively. A diag-
nostic accuracy of 89.2% (33/37) was obtained in reclassified
cases. In conclusion, the group consensus review minimized AUS/
FLUS, offered an optimal level of interobserver agreement, and
most importantly, promoted excellent cytohistologic concordance
in reclassified cases and, therefore, could play a substantial role in
the future in reducing reaspiration and/or unnecessary surgeries.
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It has been widely accepted that fine needle aspiration
(FNA) of thyroid plays an essential and critical role in the
management of thyroid nodules. For the majority of thy-
roid nodules, FNA cytologic evaluation effectively differ-
entiates neoplastic/malignant nodules requiring surgical
intervention from non-neoplastic/benign nodules that may
be managed conservatively with clinical and radiologic
follow-up.1–4 However, in a subset of cases, FNA cytology
of thyroid nodules exhibits cytomorphologic features that
are neither convincingly non-neoplastic/benign nor suffi-
cient for neoplasia/malignancy, and a definitive cytologic
interpretation (non-neoplasia/benign versus neoplasia/
malignancy) cannot be established. Instead, in these cases,
an indeterminate interpretation such as ‘‘atypia of undeter-
mined significance/follicular lesion of undetermined signif-
icance’’ (AUS/FLUS) is rendered.5–7 Recognizing the con-
siderable variation among both pathologists and institu-
tions in diagnosing indeterminate lesions, the newly
published The Bethesda System for Reporting Thyroid
Cytology (BSRTC) defines the diagnostic criteria for AUS/
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FLUS and advises judicious use of this diagnostic termi-
nology.8
FNA of thyroid nodules has been an established prac-
tice within our institution. Currently, the cytology service
assesses more than 800 thyroid FNA specimens per year,
of which nearly 6% are classified as AUS/FLUS. Data
from a previous study at our institution demonstrated that
using proposed standard morphological criteria similar to
those of the BSRTC, in conjunction with independent sec-
ond review, reduces the diagnosis of AUS/FLUS and
improves cytohistologic correlation.9 The current study
was undertaken to investigate if group consensus review
would minimize AUS/FLUS diagnoses with optimal inter-
observer agreement while also promoting a better cytohis-
tologic concordance.
Materials and Methods
A SNOMED search of the electronic pathology database
in our institution for the period between January 1998 and
June 2010 retrieved a total of 217 aspirates in which the
original cytologic interpretation of AUS/FLUS was ren-
dered and that were followed by hemi- or total thyroidec-
tomies. For the retrospective consensus review, 50 aspi-
rates were selected by choosing the first 50 consecutive
cases in which a complete set of smears prepared from
each aspirate was available. Forty-six of the 50 aspirates
consisted of conventional air-dried Diff-Quik and alcohol-
fixed Papanicolaou smears along with ThinPrep and/or
cell block preparations; the remaining four aspirates con-
tained ThinPrep and cell block preparation only. A group
of reviewers, who were blinded to the corresponding his-
tologic findings, simultaneously evaluated slides of each
aspirate at a multiheaded light microscope. Reviewers
were two cytopathology fellows (KH, JP), three junior
(with 2–4 years of experience, XJ, SMK, MHR), and
three senior cytopathologists (with more than 15 years of
experience, RD, RR, CWM). At least five reviewers rep-
resenting both junior and senior levels participated in the
evaluation of each individual aspirate. Using the BSRTC
as a guideline, individual interpretation was presented fol-
lowing the ascending order of the reviewer’s levels of ex-
perience, and a consensus interpretation was then reached
at the end of the group review. Interobserver agreement
was calculated by dividing diagnosis of the majority by
the total. For example, interobserver agreement for an
individual aspirate was 100% if all participating reviewers
agreed on the cytologic interpretation for an individual
aspirate; however, interobserver agreement would
decrease to 60% if three out of five participating
reviewers concurred with the interpretation, while the
other two reviewers disagreed with the interpretation.
Mean interobserver agreement was calculated for each
category at the end of the study. For each aspirate, the
cytohistologic correlation (the consensus interpretation
versus the corresponding histologic diagnoses) was per-
formed immediately upon obtaining the consensus cyto-
logic interpretation. Cytologic features of each aspirate
were discussed in detail throughout the group consensus
review. To assess if reviewers gained positive feedback
through the approach of immediate cytohistologic correla-
tion, we excluded two aspirates reclassified as nondiag-
nostic specimen and then compared performance of the
consensus review between earlier (review of first 24 diag-
nostic aspirates) and later phase (review of last 24 diag-
nostic aspirates).
Results
Using BSRTC8 as a guideline, the group consensus review
of 50 thyroid aspirates previously interpreted as AUS/
FLUS resulted in reclassification of 26 (52%) aspirates as
non-neoplasia/benign, including nodular hyperplasia and
chronic lymphocytic thyroiditis, 10 (20%) aspirates as fol-
licular neoplasm/suspicious for a follicular neoplasm (FN/
SFN), 1 (2%) aspirate as papillary thyroid carcinoma
(PTC), and 2 (4%) aspirates as nondiagnostic because of
the insufficient number of follicular cells. On the other
hand, 11 (22%) aspirates remained AUS/FLUS following
the group review. The interobserver agreement across the
five diagnostic categories ranged from 71.6% for AUS/
FLUS to 100% for PTC and nondiagnostic with an average
level of 88.8% (Table I). Table I also shows correlation
between the cytologic interpretations rendered by the group
consensus review and the corresponding histologic diagno-
ses. Cytohistologic concordance was achieved in 24 of 26
(92.3%) and 9 of 11 (81.8%) aspirates that were reclassified
as non-neoplasia/benign (Fig. 1) and neoplasia/malignancy
(Figs. 2 and 3), respectively. The histology-proved neopla-
sia/malignancy included six follicular adenomas and three
Table I. Correlation Between Consensus Cytologic Interpretation and Histologic Diagnosis
Cytologic diagnosis Interobserver agreement (%)
Histologic Diagnosis
Benign (non-neoplastic) Follicular adenoma Follicular carcinoma PTC Total (%)
Nondiagnostic 100 2 — — — 2 (4)
Benign 90.5 24 2 — — 26 (52)
AUS/FLUS 71.6 5 3 2 1 11 (22)
FN/SFN 81.8 2 5 1 2 10 (20)
PTC 100 — — — 1 1 (2)
Total — 33 10 3 4 50 (100)
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PTC among which two were follicular variant of PTC. A
diagnostic accuracy of 89.2% (33/37) was obtained in the
reclassified aspirates. Cytologic misinterpretation during
the group review contributed to the false-negative and
false-positive interpretations. Dividing the study period into
earlier (review of first 24 diagnostic aspirates) and later
phase (review of last 24 diagnostic aspirates), 20 and 13
aspirates with cytohistologic concordance were reviewed
during later and earlier phase of the study, respectively; all
four aspirates with cytohistologic discordance were reas-
sessed during the early phase of the group review. Addi-
tionally, out of 11 aspirates remained as AUS/FLUS, 7 and
4 aspirates were results of earlier and later group review,
respectively (Table II).
Histologic examination of the 11 aspirates remaining as
AUS/FLUS revealed five benign diagnoses, three follicu-
lar adenomas, two follicular carcinomas, and one conven-
tional PTC. Thus, malignancy was detected in correspond-
ing surgical specimens in 27% (3/11) of the remaining
indeterminate aspirates.
Discussion
Profound variations among both pathologists (i.e., 2.5–
28.6%) and institutions (i.e., 3.3–14.9%) have been previ-
ously described with regard to applying the indeterminate
diagnostic terminology for FNA cytology evaluation of
thyroid nodules.10 One of the dominant contributing fac-
tors leading to the variation is the lack of precisely
defined, objective morphological criteria.10–12 In addition,
threshold level and stringency in applying the diagnostic
criteria may differ among reviewers and institutions.
According to the newly published BSRTC,8 AUS/FLUS
Fig. 1. A nodule reclassified as nodular hyperplasia. (A) and (B): Hypercellular aspirate composed of follicular cells that are arranged in large tissue
fragments and intact follicles (Diff-Quik, 3100). (C): Higher power view showing honeycomb pattern with evenly distributed, uniform nuclei (Diff-
Quik, 3600). (D): Histology showing nodular hyperplasia (H&E, 3100). [Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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is mainly reserved for aspirates with architectural and/or
cytologic atypia that is not sufficient to be categorized as
suspicious for neoplasia/malignancy, yet on the other
hand, is more marked than can be ascribed confidently to
benign changes. BSRTC recommends the indeterminate
interpretation be used in <7% of all thyroid FNA inter-
pretation and suggests clinical correlation and repeat
aspiration after an appropriate interval following initial
Fig. 2. A nodule reclassified as follicular neoplasm. (A): Hypercellular
aspirate consisted of numerous microfollicles with nuclear crowding/over-
lapping (Diff-Quik, 3100). (B): The follicular cells demonstrate marked
cytologic atypia (Diff-Quik, 3400). (C): Histology revealing follicular
carcinoma (H&E, 3100). [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
Fig. 3. A nodule reclassified as papillary thyroid carcinoma. (A) and
(B): ThinPrep preparation showing follicular cells that are arranged in
syncytial sheets. The nuclei exhibit features of papillary thyroid carci-
noma (Papanicolaou, 3600). (C): Histology revealing papillary thyroid
carcinoma (H&E, 3400). [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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indeterminate interpretation.8 In our institution, nearly 6%
of all thyroid aspirates fall into the indeterminate category
during the last 12 years. On the other hand, virtually all
thyroid nodules categorized as AUS/FLUS at our institu-
tion were managed with surgical interventions prior to the
implementation of the newly published BSRTC recom-
mendation.
Our data demonstrates that using BSRTC as a guide-
line, group consensus review of the aspirates previously
categorized as AUS/FLUS: (1) minimizes AUS/FLUS
without compromising diagnostic accuracy; (2) achieves
an optimal level of interobserver agreement; and (3) pro-
motes a better cytohistologic concordance and diagnostic
accuracy. Overall, the group consensus review could have
played a substantial role in reducing unnecessary surgical
intervention, and more than 90% of non-neoplastic/benign
thyroid nodules could have been managed with clinical/
radiological follow-up instead of surgical intervention.
In comparison to results of our previously published
data generated from the individualized second review of
123 indeterminate thyroid aspirates,9 the current data
illustrates an identical distribution in the diagnostic cate-
gories of both non-neoplasia/benign (52%) and neoplasia/
malignancy (22%). The percentage of remaining AUS/
FLUS in the current study (22%) appears to be slightly
lower than that of prior study (26%). We thus believe that
previously categorized indeterminate lesions in our insti-
tution were well-represented by the 50 aspirates in the
study. However, it is noteworthy that a more accurate
cytohistologic concordance is achieved in the current
study for both non-neoplasia/benign (92.3% versus
73.4%) and neoplasia/malignancy (81.8% versus 55.6%).
Thus, the current data demonstrates a higher level of
diagnostic accuracy for reclassified aspirates (89.2% ver-
sus 68.1%). Considering that both studies employed simi-
lar cytomorphologic criteria as a guideline, we suggest
that in addition to the approach of consensus review itself,
positive feedback obtained through cytohistologic correla-
tion performed immediately upon completion of the group
review of each aspirate played a significant role in real-
time affirmation of the diagnostic cytologic features.
In this regard, it is interesting to see that later phase of
the study generated more cytohistologic concordant cases
(n ¼ 20) compared with earlier phase (n ¼ 13), none of
the cytohistologic discordant cases occurred during the
later phase and furthermore, later phase of the study gen-
erated less AUS/FLUS (n ¼ 4) compared with earlier
phase (n ¼ 7). We believe that the group consensus review
along with a consistent and effective feedback contributed
to marked improvement in diagnostic accuracy. In fact,
diagnostic accuracy obtained in the current study is compa-
tible to the previously reported data, which were generated
from a study of general cohort of thyroid aspirates.13 The
findings support our postulate that the refined consensual
approach combined with a consistent and effective feed-
back brings enhanced accuracy in the categorization of the
thyroid lesions that pose diagnostic challenges.
With regard to assessing influence of reviewer’s experi-
ence on classifying aspirates as AUS/FLUS, we were fully
aware that different conclusions were drawn from the stud-
ies that used different approaches. For example, a review
of original cytology reports from multi-institutions did not
show a relationship between the level of reviewer’s expe-
rience and usage of the indeterminate terminology,10 while
a cytologic re-review of previously diagnosed indetermi-
nate lesions demonstrated less usage of the indeterminate
terminology by the reviewers with more experience.11 We
believed that it is unlikely to generate additional informa-
tion by applying the similar approaches to our existing
cohort of AUS/FLUS. Thus, the current study focused on
the role of group consensus review in the reassessment of
previously categorized indeterminate aspirates. Before
reaching a consensus interpretation for each aspirate, indi-
vidual interpretation was presented following the ascend-
ing order of the reviewer’s levels of experience so that the
junior reviewers made their decision without being influ-
enced by the senior reviewers. Noting that the reassess-
ment was performed on the thyroid lesions with diagnostic
challenges, the interobserver agreement across the diagnos-
tic categories descended in the following order: malignant
PTC (100%) > non-neoplasia/benign (90.5%) > FN/SFN
(81.8%) > AUS/FLUS (71.6%). Not surprisingly, the least
interobserver agreement was obtained for the category of
AUS/FLUS.
Different approaches are explored for further stratifica-
tion of thyroid lesions categorized as AUS/FLUS. In this
regard, potential benefit of applying molecular analysis as
an adjunct of FNA cytology has been investigated.14,15
Regardless, the cytomorphologic assessment is an essen-
tial and critical, as well as a cost-effective, method in the
management of thyroid nodules.
In conclusion, the group consensus review minimized
AUS/FLUS, offered an optimal level of interobserver
agreement, and most importantly, promoted excellent
cytohistologic concordance in reclassified cases and,
therefore, could play a substantial role in the future in
reducing reaspiration and/or unnecessary surgeries.
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